A critical breakthrough in cancer research is emerging with the use of nanobodies to restore damaged p53. This crucial tumor inhibitor protein is frequently inactivated in several forms of tumors, resulting https://listbell.com/story11909757/mini-antibodies-reactivate-p53-a-new-hope-for-cancer-management